Section Arrow
Quote
AVR.NASDAQ
- Anteris Technologies Global Corp
Quotes are at least 15-min delayed:2025/01/21 02:11 EST
Last
 5.99
-0.01 (-0.17%)
Day High 
6 
Prev. Close
6 
1-M High
6.1 
Volume 
52.46K 
Bid
5.6
Ask
6
Day Low
5.9 
Open
5.94 
1-M Low
5.25 
Market Cap 
215.64M 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 5.72 
20-SMA 5.66 
50-SMA -- 
52-W High 6.1 
52-W Low 5.1 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.66/--
Enterprise Value
217.17M
Balance Sheet
Book Value Per Share
0.09
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
2.73M
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
QSIQuantum-Si2.24-0.3-11.81%-- 
SENSSenseonics Holdings0.8479-0.0271-3.10%-- 
BDMDBaird Medical Investment Holdings Ltd8.85+3.43+63.28%15.32PE
BMRABiomerica0.64-0.066-9.35%-- 
MDTMedtronic plc88.08+0.92+1.06%26.61PE
Quotes are at least 15-min delayed：2025/01/21 02:11 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
Anteris Technologies Global Corp is a structural heart company committed to designing, developing, and commercializing cutting-edge medical devices to restore healthy heart function. Its product, the DurAVR Transcatheter Heart Valve (THV),was designed in partnership with the world's interventional cardiologists and cardiac surgeons to treat aortic stenosis - a potentially life-threatening condition resulting from the narrowing of the aortic valve. The balloon-expandable DurAVR THV is the first biomimetic valve, which is shaped to mimic the performance of a healthy human aortic valve and aims to replicate normal aortic blood flow.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.